Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury

NCT07742878 is registered in ClinicalTrials.gov with Rebiscan, Inc. as lead sponsor.

NCT NCT07742878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07742878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury
Lead sponsor
Rebiscan, Inc.
Phase
Observational
Overall status
Recruiting
Start date
July 14, 2026
Completion date
October 31, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

binocular visual function, mild traumatic brain injury, concussion, neuro-ophthalmology, saccadic eye movements